MG
TGAN

Michael Gelband’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Michael Gelband’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,998
Closed -$126K – 2405
2022
Q2 		$126K Sell
32,998
-56,501
-63% -$361K ﹤0.01% 1722
2022
Q1 		$633K Buy
+89,499
New +$629K 0.01% 1399

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Michael Gelband's TGAN Position: Q3 2022 in Review

Michael Gelband sold out of Transphorm, Inc. Common Stock (TGAN) in Q3 2022, closing a stake of 32,998 shares — an estimated $126K sold.

Michael Gelband first reported a position in TGAN in Q1 2022 and held it in 2 quarters. The position peaked at $633K in Q1 2022. 38 funds tracked by Wall St. Rank hold TGAN as of Q3 2022.

  • Michael Gelband reported no remaining Transphorm, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 32,998 Transphorm, Inc. Common Stock shares in Q3 2022, an estimated $126K.
  • Michael Gelband first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Michael Gelband's Transphorm, Inc. Common Stock position peaked at $633K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.